nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.326	1	CpDpCtD
Modafinil—CYP1A2—type 2 diabetes mellitus	0.12	0.602	CbGaD
Modafinil—CYP3A4—type 2 diabetes mellitus	0.0796	0.398	CbGaD
Modafinil—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0234	0.0735	CbGbCtD
Modafinil—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0144	0.0453	CbGbCtD
Modafinil—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0141	0.0443	CbGbCtD
Modafinil—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0129	0.0405	CbGbCtD
Modafinil—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0122	0.0385	CbGbCtD
Modafinil—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0122	0.0385	CbGbCtD
Modafinil—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.012	0.0376	CbGbCtD
Modafinil—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0115	0.0362	CbGbCtD
Modafinil—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0113	0.0355	CbGbCtD
Modafinil—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0109	0.0343	CbGbCtD
Modafinil—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0104	0.0328	CbGbCtD
Modafinil—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0102	0.032	CbGbCtD
Modafinil—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0102	0.032	CbGbCtD
Modafinil—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00939	0.0295	CbGbCtD
Modafinil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00918	0.0289	CbGbCtD
Modafinil—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00907	0.0285	CbGbCtD
Modafinil—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00829	0.0261	CbGbCtD
Modafinil—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0082	0.0258	CbGbCtD
Modafinil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00818	0.0257	CbGbCtD
Modafinil—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00776	0.0244	CbGbCtD
Modafinil—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00771	0.0242	CbGbCtD
Modafinil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00748	0.0235	CbGbCtD
Modafinil—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00739	0.0232	CbGbCtD
Modafinil—CYP3A5—Losartan—type 2 diabetes mellitus	0.0071	0.0223	CbGbCtD
Modafinil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00654	0.0206	CbGbCtD
Modafinil—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00626	0.0197	CbGbCtD
Modafinil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00592	0.0186	CbGbCtD
Modafinil—CYP2C19—Losartan—type 2 diabetes mellitus	0.00573	0.018	CbGbCtD
Modafinil—CYP1A2—Losartan—type 2 diabetes mellitus	0.00529	0.0166	CbGbCtD
Modafinil—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00521	0.0164	CbGbCtD
Modafinil—CYP2C9—Losartan—type 2 diabetes mellitus	0.00476	0.015	CbGbCtD
Modafinil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00448	0.0141	CbGbCtD
Modafinil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0043	0.0135	CbGbCtD
Modafinil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0043	0.0135	CbGbCtD
Modafinil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00406	0.0128	CbGbCtD
Modafinil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00303	0.00952	CbGbCtD
Modafinil—CYP3A4—Losartan—type 2 diabetes mellitus	0.00277	0.00871	CbGbCtD
Modafinil—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000141	0.0695	CrCbGaD
Modafinil—Bifonazole—CYP2E1—type 2 diabetes mellitus	8.54e-05	0.0422	CrCbGaD
Modafinil—Nepafenac—PTGS2—type 2 diabetes mellitus	8.04e-05	0.0397	CrCbGaD
Modafinil—Carbamazepine—ABCC2—type 2 diabetes mellitus	7.3e-05	0.036	CrCbGaD
Modafinil—Fosphenytoin—CYP3A4—type 2 diabetes mellitus	7.1e-05	0.0351	CrCbGaD
Modafinil—Phenytoin—ABCC2—type 2 diabetes mellitus	7.09e-05	0.035	CrCbGaD
Modafinil—Oxaprozin—PTGS2—type 2 diabetes mellitus	6.68e-05	0.033	CrCbGaD
Modafinil—Benzphetamine—ADRA2A—type 2 diabetes mellitus	6.66e-05	0.0329	CrCbGaD
Modafinil—Warfarin—CYP1A2—type 2 diabetes mellitus	6.52e-05	0.0322	CrCbGaD
Modafinil—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	6.37e-05	0.0315	CrCbGaD
Modafinil—Fosphenytoin—ALB—type 2 diabetes mellitus	6.19e-05	0.0306	CrCbGaD
Modafinil—Atomoxetine—HTR2C—type 2 diabetes mellitus	6.09e-05	0.0301	CrCbGaD
Modafinil—Fenoprofen—PTGS2—type 2 diabetes mellitus	5.52e-05	0.0273	CrCbGaD
Modafinil—Bifonazole—CYP3A4—type 2 diabetes mellitus	5.38e-05	0.0266	CrCbGaD
Modafinil—Cinnarizine—CYP1A2—type 2 diabetes mellitus	5.17e-05	0.0255	CrCbGaD
Modafinil—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000444	CcSEcCtD
Modafinil—Shock—Metformin—type 2 diabetes mellitus	5.07e-05	0.000444	CcSEcCtD
Modafinil—Insomnia—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000442	CcSEcCtD
Modafinil—Malaise—Losartan—type 2 diabetes mellitus	5.06e-05	0.000442	CcSEcCtD
Modafinil—Anxiety—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000442	CcSEcCtD
Modafinil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.05e-05	0.000442	CcSEcCtD
Modafinil—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.05e-05	0.000442	CcSEcCtD
Modafinil—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000441	CcSEcCtD
Modafinil—Vertigo—Losartan—type 2 diabetes mellitus	5.04e-05	0.000441	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000441	CcSEcCtD
Modafinil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.04e-05	0.000441	CcSEcCtD
Modafinil—Somnolence—Valsartan—type 2 diabetes mellitus	5.03e-05	0.00044	CcSEcCtD
Modafinil—Syncope—Losartan—type 2 diabetes mellitus	5.03e-05	0.00044	CcSEcCtD
Modafinil—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.02e-05	0.000439	CcSEcCtD
Modafinil—Discomfort—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000438	CcSEcCtD
Modafinil—Skin disorder—Metformin—type 2 diabetes mellitus	5.01e-05	0.000438	CcSEcCtD
Modafinil—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000436	CcSEcCtD
Modafinil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.98e-05	0.000436	CcSEcCtD
Modafinil—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.98e-05	0.000436	CcSEcCtD
Modafinil—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000435	CcSEcCtD
Modafinil—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.96e-05	0.000434	CcSEcCtD
Modafinil—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000434	CcSEcCtD
Modafinil—Palpitations—Losartan—type 2 diabetes mellitus	4.96e-05	0.000434	CcSEcCtD
Modafinil—Nausea—Glimepiride—type 2 diabetes mellitus	4.94e-05	0.000432	CcSEcCtD
Modafinil—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000432	CcSEcCtD
Modafinil—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.93e-05	0.000431	CcSEcCtD
Modafinil—Nausea—Sitagliptin—type 2 diabetes mellitus	4.93e-05	0.000431	CcSEcCtD
Modafinil—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.92e-05	0.000431	CcSEcCtD
Modafinil—Asthenia—Glyburide—type 2 diabetes mellitus	4.92e-05	0.000431	CcSEcCtD
Modafinil—Fenoprofen—ALB—type 2 diabetes mellitus	4.92e-05	0.0243	CrCbGaD
Modafinil—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.92e-05	0.00043	CcSEcCtD
Modafinil—Anorexia—Metformin—type 2 diabetes mellitus	4.91e-05	0.00043	CcSEcCtD
Modafinil—Cough—Losartan—type 2 diabetes mellitus	4.89e-05	0.000428	CcSEcCtD
Modafinil—Urticaria—Gliclazide—type 2 diabetes mellitus	4.89e-05	0.000428	CcSEcCtD
Modafinil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000427	CcSEcCtD
Modafinil—Fatigue—Valsartan—type 2 diabetes mellitus	4.88e-05	0.000427	CcSEcCtD
Modafinil—Carbamazepine—CYP1A2—type 2 diabetes mellitus	4.87e-05	0.0241	CrCbGaD
Modafinil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.87e-05	0.000426	CcSEcCtD
Modafinil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.87e-05	0.000426	CcSEcCtD
Modafinil—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	4.86e-05	0.024	CrCbGaD
Modafinil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000425	CcSEcCtD
Modafinil—Oedema—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000425	CcSEcCtD
Modafinil—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.86e-05	0.000425	CcSEcCtD
Modafinil—Pruritus—Glyburide—type 2 diabetes mellitus	4.85e-05	0.000425	CcSEcCtD
Modafinil—Mental disorder—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000423	CcSEcCtD
Modafinil—Constipation—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000423	CcSEcCtD
Modafinil—Infection—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000423	CcSEcCtD
Modafinil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.83e-05	0.000422	CcSEcCtD
Modafinil—Fatigue—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000422	CcSEcCtD
Modafinil—Hypotension—Metformin—type 2 diabetes mellitus	4.82e-05	0.000421	CcSEcCtD
Modafinil—Malnutrition—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000421	CcSEcCtD
Modafinil—Shock—Irbesartan—type 2 diabetes mellitus	4.79e-05	0.000419	CcSEcCtD
Modafinil—Pain—Orlistat—type 2 diabetes mellitus	4.78e-05	0.000418	CcSEcCtD
Modafinil—Chest pain—Losartan—type 2 diabetes mellitus	4.77e-05	0.000418	CcSEcCtD
Modafinil—Myalgia—Losartan—type 2 diabetes mellitus	4.77e-05	0.000418	CcSEcCtD
Modafinil—Arthralgia—Losartan—type 2 diabetes mellitus	4.77e-05	0.000418	CcSEcCtD
Modafinil—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.77e-05	0.000417	CcSEcCtD
Modafinil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000417	CcSEcCtD
Modafinil—Anxiety—Losartan—type 2 diabetes mellitus	4.76e-05	0.000416	CcSEcCtD
Modafinil—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000415	CcSEcCtD
Modafinil—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	4.73e-05	0.0234	CrCbGaD
Modafinil—Rash—Bromocriptine—type 2 diabetes mellitus	4.73e-05	0.000414	CcSEcCtD
Modafinil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.73e-05	0.000413	CcSEcCtD
Modafinil—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000413	CcSEcCtD
Modafinil—Tension—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000413	CcSEcCtD
Modafinil—Discomfort—Losartan—type 2 diabetes mellitus	4.72e-05	0.000413	CcSEcCtD
Modafinil—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000412	CcSEcCtD
Modafinil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000411	CcSEcCtD
Modafinil—Headache—Bromocriptine—type 2 diabetes mellitus	4.7e-05	0.000411	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.7e-05	0.000411	CcSEcCtD
Modafinil—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.69e-05	0.000411	CcSEcCtD
Modafinil—Nervousness—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000409	CcSEcCtD
Modafinil—Dry mouth—Losartan—type 2 diabetes mellitus	4.67e-05	0.000408	CcSEcCtD
Modafinil—Anorexia—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000406	CcSEcCtD
Modafinil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.63e-05	0.000405	CcSEcCtD
Modafinil—Paraesthesia—Metformin—type 2 diabetes mellitus	4.63e-05	0.000405	CcSEcCtD
Modafinil—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000404	CcSEcCtD
Modafinil—Confusional state—Losartan—type 2 diabetes mellitus	4.62e-05	0.000404	CcSEcCtD
Modafinil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.61e-05	0.000403	CcSEcCtD
Modafinil—Dyspnoea—Metformin—type 2 diabetes mellitus	4.6e-05	0.000402	CcSEcCtD
Modafinil—Somnolence—Metformin—type 2 diabetes mellitus	4.58e-05	0.000401	CcSEcCtD
Modafinil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.58e-05	0.0004	CcSEcCtD
Modafinil—Oedema—Losartan—type 2 diabetes mellitus	4.58e-05	0.0004	CcSEcCtD
Modafinil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.57e-05	0.0004	CcSEcCtD
Modafinil—Infection—Losartan—type 2 diabetes mellitus	4.55e-05	0.000398	CcSEcCtD
Modafinil—Hypotension—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000398	CcSEcCtD
Modafinil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.54e-05	0.000397	CcSEcCtD
Modafinil—Dyspepsia—Metformin—type 2 diabetes mellitus	4.54e-05	0.000397	CcSEcCtD
Modafinil—Phenylbutazone—CYP3A4—type 2 diabetes mellitus	4.51e-05	0.0223	CrCbGaD
Modafinil—Tremor—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000394	CcSEcCtD
Modafinil—Shock—Losartan—type 2 diabetes mellitus	4.5e-05	0.000394	CcSEcCtD
Modafinil—Urticaria—Valsartan—type 2 diabetes mellitus	4.5e-05	0.000393	CcSEcCtD
Modafinil—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.49e-05	0.000393	CcSEcCtD
Modafinil—Decreased appetite—Metformin—type 2 diabetes mellitus	4.48e-05	0.000392	CcSEcCtD
Modafinil—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.47e-05	0.000391	CcSEcCtD
Modafinil—Tachycardia—Losartan—type 2 diabetes mellitus	4.47e-05	0.000391	CcSEcCtD
Modafinil—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.46e-05	0.00039	CcSEcCtD
Modafinil—Nausea—Bromocriptine—type 2 diabetes mellitus	4.46e-05	0.00039	CcSEcCtD
Modafinil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.45e-05	0.000389	CcSEcCtD
Modafinil—Fatigue—Metformin—type 2 diabetes mellitus	4.44e-05	0.000389	CcSEcCtD
Modafinil—Urticaria—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000389	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000388	CcSEcCtD
Modafinil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.43e-05	0.000387	CcSEcCtD
Modafinil—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.42e-05	0.000387	CcSEcCtD
Modafinil—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.42e-05	0.000387	CcSEcCtD
Modafinil—Asthenia—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000387	CcSEcCtD
Modafinil—Agitation—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000387	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—type 2 diabetes mellitus	4.42e-05	0.0218	CrCbGaD
Modafinil—Constipation—Metformin—type 2 diabetes mellitus	4.41e-05	0.000386	CcSEcCtD
Modafinil—Angioedema—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000384	CcSEcCtD
Modafinil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000382	CcSEcCtD
Modafinil—Anorexia—Losartan—type 2 diabetes mellitus	4.36e-05	0.000382	CcSEcCtD
Modafinil—Vomiting—Glyburide—type 2 diabetes mellitus	4.36e-05	0.000382	CcSEcCtD
Modafinil—Pruritus—Gliclazide—type 2 diabetes mellitus	4.36e-05	0.000381	CcSEcCtD
Modafinil—Malaise—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000379	CcSEcCtD
Modafinil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000379	CcSEcCtD
Modafinil—Rash—Glyburide—type 2 diabetes mellitus	4.33e-05	0.000378	CcSEcCtD
Modafinil—Somnolence—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000378	CcSEcCtD
Modafinil—Dermatitis—Glyburide—type 2 diabetes mellitus	4.32e-05	0.000378	CcSEcCtD
Modafinil—Vertigo—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000378	CcSEcCtD
Modafinil—Warfarin—CYP3A4—type 2 diabetes mellitus	4.32e-05	0.0213	CrCbGaD
Modafinil—Syncope—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000377	CcSEcCtD
Modafinil—Headache—Glyburide—type 2 diabetes mellitus	4.3e-05	0.000376	CcSEcCtD
Modafinil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000374	CcSEcCtD
Modafinil—Hypotension—Losartan—type 2 diabetes mellitus	4.28e-05	0.000374	CcSEcCtD
Modafinil—Palpitations—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000372	CcSEcCtD
Modafinil—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.25e-05	0.000371	CcSEcCtD
Modafinil—Phenprocoumon—ALB—type 2 diabetes mellitus	4.24e-05	0.021	CrCbGaD
Modafinil—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.00037	CcSEcCtD
Modafinil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.23e-05	0.00037	CcSEcCtD
Modafinil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.21e-05	0.000369	CcSEcCtD
Modafinil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.21e-05	0.000369	CcSEcCtD
Modafinil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000367	CcSEcCtD
Modafinil—Cough—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000367	CcSEcCtD
Modafinil—Fatigue—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000367	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.17e-05	0.000365	CcSEcCtD
Modafinil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.17e-05	0.000365	CcSEcCtD
Modafinil—Convulsion—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000364	CcSEcCtD
Modafinil—Constipation—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000364	CcSEcCtD
Modafinil—Pain—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000364	CcSEcCtD
Modafinil—Insomnia—Losartan—type 2 diabetes mellitus	4.14e-05	0.000362	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—type 2 diabetes mellitus	4.13e-05	0.0204	CrCbGaD
Modafinil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.12e-05	0.00036	CcSEcCtD
Modafinil—Paraesthesia—Losartan—type 2 diabetes mellitus	4.11e-05	0.00036	CcSEcCtD
Modafinil—Urticaria—Metformin—type 2 diabetes mellitus	4.09e-05	0.000358	CcSEcCtD
Modafinil—Chest pain—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000358	CcSEcCtD
Modafinil—Arthralgia—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000358	CcSEcCtD
Modafinil—Myalgia—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000358	CcSEcCtD
Modafinil—Dyspnoea—Losartan—type 2 diabetes mellitus	4.08e-05	0.000357	CcSEcCtD
Modafinil—Anxiety—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000357	CcSEcCtD
Modafinil—Nausea—Glyburide—type 2 diabetes mellitus	4.08e-05	0.000356	CcSEcCtD
Modafinil—Abdominal pain—Metformin—type 2 diabetes mellitus	4.07e-05	0.000356	CcSEcCtD
Modafinil—Dizziness—Gliclazide—type 2 diabetes mellitus	4.07e-05	0.000356	CcSEcCtD
Modafinil—Somnolence—Losartan—type 2 diabetes mellitus	4.07e-05	0.000356	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000356	CcSEcCtD
Modafinil—Asthenia—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000355	CcSEcCtD
Modafinil—Discomfort—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000354	CcSEcCtD
Modafinil—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	4.04e-05	0.02	CrCbGaD
Modafinil—Dyspepsia—Losartan—type 2 diabetes mellitus	4.03e-05	0.000352	CcSEcCtD
Modafinil—Asthenia—Orlistat—type 2 diabetes mellitus	4.01e-05	0.000351	CcSEcCtD
Modafinil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000351	CcSEcCtD
Modafinil—Pruritus—Valsartan—type 2 diabetes mellitus	4e-05	0.00035	CcSEcCtD
Modafinil—Dry mouth—Ramipril—type 2 diabetes mellitus	4e-05	0.00035	CcSEcCtD
Modafinil—Decreased appetite—Losartan—type 2 diabetes mellitus	3.98e-05	0.000348	CcSEcCtD
Modafinil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.98e-05	0.000348	CcSEcCtD
Modafinil—Confusional state—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000346	CcSEcCtD
Modafinil—Pruritus—Orlistat—type 2 diabetes mellitus	3.96e-05	0.000346	CcSEcCtD
Modafinil—Fatigue—Losartan—type 2 diabetes mellitus	3.95e-05	0.000345	CcSEcCtD
Modafinil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000343	CcSEcCtD
Modafinil—Oedema—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000343	CcSEcCtD
Modafinil—Vomiting—Gliclazide—type 2 diabetes mellitus	3.92e-05	0.000343	CcSEcCtD
Modafinil—Constipation—Losartan—type 2 diabetes mellitus	3.91e-05	0.000342	CcSEcCtD
Modafinil—Pain—Losartan—type 2 diabetes mellitus	3.91e-05	0.000342	CcSEcCtD
Modafinil—Rash—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.00034	CcSEcCtD
Modafinil—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000339	CcSEcCtD
Modafinil—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.87e-05	0.000339	CcSEcCtD
Modafinil—Urticaria—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000338	CcSEcCtD
Modafinil—Shock—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000338	CcSEcCtD
Modafinil—Headache—Gliclazide—type 2 diabetes mellitus	3.86e-05	0.000338	CcSEcCtD
Modafinil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000337	CcSEcCtD
Modafinil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000336	CcSEcCtD
Modafinil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000336	CcSEcCtD
Modafinil—Tachycardia—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000335	CcSEcCtD
Modafinil—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.83e-05	0.000335	CcSEcCtD
Modafinil—Skin disorder—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000333	CcSEcCtD
Modafinil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000332	CcSEcCtD
Modafinil—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.77e-05	0.00033	CcSEcCtD
Modafinil—Warfarin—ALB—type 2 diabetes mellitus	3.76e-05	0.0186	CrCbGaD
Modafinil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.74e-05	0.000327	CcSEcCtD
Modafinil—Dizziness—Valsartan—type 2 diabetes mellitus	3.74e-05	0.000327	CcSEcCtD
Modafinil—Anorexia—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000327	CcSEcCtD
Modafinil—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	3.71e-05	0.0183	CrCbGaD
Modafinil—Dizziness—Orlistat—type 2 diabetes mellitus	3.7e-05	0.000323	CcSEcCtD
Modafinil—Asthenia—Metformin—type 2 diabetes mellitus	3.7e-05	0.000323	CcSEcCtD
Modafinil—Orphenadrine—CYP2E1—type 2 diabetes mellitus	3.69e-05	0.0182	CrCbGaD
Modafinil—Hypotension—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000321	CcSEcCtD
Modafinil—Nausea—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.00032	CcSEcCtD
Modafinil—Pruritus—Metformin—type 2 diabetes mellitus	3.65e-05	0.000319	CcSEcCtD
Modafinil—Urticaria—Losartan—type 2 diabetes mellitus	3.64e-05	0.000318	CcSEcCtD
Modafinil—Abdominal pain—Losartan—type 2 diabetes mellitus	3.62e-05	0.000316	CcSEcCtD
Modafinil—Body temperature increased—Losartan—type 2 diabetes mellitus	3.62e-05	0.000316	CcSEcCtD
Modafinil—Vomiting—Valsartan—type 2 diabetes mellitus	3.6e-05	0.000315	CcSEcCtD
Modafinil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.58e-05	0.000313	CcSEcCtD
Modafinil—Methadone—CYP1A2—type 2 diabetes mellitus	3.58e-05	0.0177	CrCbGaD
Modafinil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000313	CcSEcCtD
Modafinil—Rash—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000312	CcSEcCtD
Modafinil—Dermatitis—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000312	CcSEcCtD
Modafinil—Vomiting—Orlistat—type 2 diabetes mellitus	3.56e-05	0.000311	CcSEcCtD
Modafinil—Insomnia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.00031	CcSEcCtD
Modafinil—Headache—Valsartan—type 2 diabetes mellitus	3.55e-05	0.00031	CcSEcCtD
Modafinil—Diarrhoea—Metformin—type 2 diabetes mellitus	3.53e-05	0.000308	CcSEcCtD
Modafinil—Rash—Orlistat—type 2 diabetes mellitus	3.53e-05	0.000308	CcSEcCtD
Modafinil—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000308	CcSEcCtD
Modafinil—Dermatitis—Orlistat—type 2 diabetes mellitus	3.52e-05	0.000308	CcSEcCtD
Modafinil—Headache—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000306	CcSEcCtD
Modafinil—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000306	CcSEcCtD
Modafinil—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	3.49e-05	0.0173	CrCbGaD
Modafinil—Asthenia—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000305	CcSEcCtD
Modafinil—Somnolence—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000305	CcSEcCtD
Modafinil—Fentanyl—CYP3A4—type 2 diabetes mellitus	3.46e-05	0.0171	CrCbGaD
Modafinil—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000302	CcSEcCtD
Modafinil—Pruritus—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.000301	CcSEcCtD
Modafinil—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000298	CcSEcCtD
Modafinil—Dizziness—Metformin—type 2 diabetes mellitus	3.41e-05	0.000298	CcSEcCtD
Modafinil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000296	CcSEcCtD
Modafinil—Fatigue—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000296	CcSEcCtD
Modafinil—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.37e-05	0.000295	CcSEcCtD
Modafinil—Nausea—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000294	CcSEcCtD
Modafinil—Constipation—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000294	CcSEcCtD
Modafinil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000291	CcSEcCtD
Modafinil—Nausea—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000291	CcSEcCtD
Modafinil—Asthenia—Losartan—type 2 diabetes mellitus	3.28e-05	0.000287	CcSEcCtD
Modafinil—Vomiting—Metformin—type 2 diabetes mellitus	3.28e-05	0.000287	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—type 2 diabetes mellitus	3.26e-05	0.0161	CrCbGaD
Modafinil—Rash—Metformin—type 2 diabetes mellitus	3.25e-05	0.000284	CcSEcCtD
Modafinil—Dermatitis—Metformin—type 2 diabetes mellitus	3.25e-05	0.000284	CcSEcCtD
Modafinil—Pruritus—Losartan—type 2 diabetes mellitus	3.24e-05	0.000283	CcSEcCtD
Modafinil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000283	CcSEcCtD
Modafinil—Headache—Metformin—type 2 diabetes mellitus	3.23e-05	0.000282	CcSEcCtD
Modafinil—Carbamazepine—CYP3A4—type 2 diabetes mellitus	3.23e-05	0.0159	CrCbGaD
Modafinil—Dizziness—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000281	CcSEcCtD
Modafinil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000281	CcSEcCtD
Modafinil—Phenytoin—CYP3A4—type 2 diabetes mellitus	3.13e-05	0.0155	CrCbGaD
Modafinil—Diarrhoea—Losartan—type 2 diabetes mellitus	3.13e-05	0.000274	CcSEcCtD
Modafinil—Urticaria—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000273	CcSEcCtD
Modafinil—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000271	CcSEcCtD
Modafinil—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000271	CcSEcCtD
Modafinil—Vomiting—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.00027	CcSEcCtD
Modafinil—Rash—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000268	CcSEcCtD
Modafinil—Benzphetamine—CYP3A4—type 2 diabetes mellitus	3.06e-05	0.0151	CrCbGaD
Modafinil—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000268	CcSEcCtD
Modafinil—Nausea—Metformin—type 2 diabetes mellitus	3.06e-05	0.000268	CcSEcCtD
Modafinil—Headache—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000267	CcSEcCtD
Modafinil—Atomoxetine—CYP3A4—type 2 diabetes mellitus	3.04e-05	0.015	CrCbGaD
Modafinil—Dizziness—Losartan—type 2 diabetes mellitus	3.03e-05	0.000265	CcSEcCtD
Modafinil—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	2.93e-05	0.0145	CrCbGaD
Modafinil—Vomiting—Losartan—type 2 diabetes mellitus	2.91e-05	0.000255	CcSEcCtD
Modafinil—Ketoprofen—ALB—type 2 diabetes mellitus	2.9e-05	0.0143	CrCbGaD
Modafinil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000253	CcSEcCtD
Modafinil—Nausea—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000253	CcSEcCtD
Modafinil—Rash—Losartan—type 2 diabetes mellitus	2.89e-05	0.000252	CcSEcCtD
Modafinil—Dermatitis—Losartan—type 2 diabetes mellitus	2.88e-05	0.000252	CcSEcCtD
Modafinil—Headache—Losartan—type 2 diabetes mellitus	2.87e-05	0.000251	CcSEcCtD
Modafinil—Asthenia—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000246	CcSEcCtD
Modafinil—Pruritus—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000243	CcSEcCtD
Modafinil—Phenytoin—ALB—type 2 diabetes mellitus	2.73e-05	0.0135	CrCbGaD
Modafinil—Nausea—Losartan—type 2 diabetes mellitus	2.72e-05	0.000238	CcSEcCtD
Modafinil—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000235	CcSEcCtD
Modafinil—Dizziness—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000227	CcSEcCtD
Modafinil—Vomiting—Ramipril—type 2 diabetes mellitus	2.5e-05	0.000218	CcSEcCtD
Modafinil—Rash—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000216	CcSEcCtD
Modafinil—Dermatitis—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000216	CcSEcCtD
Modafinil—Headache—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000215	CcSEcCtD
Modafinil—Methadone—CYP3A4—type 2 diabetes mellitus	2.37e-05	0.0117	CrCbGaD
Modafinil—Nausea—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000204	CcSEcCtD
Modafinil—Orphenadrine—CYP3A4—type 2 diabetes mellitus	2.32e-05	0.0115	CrCbGaD
Modafinil—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	3.83e-06	9.69e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.82e-06	9.66e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.79e-06	9.59e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.79e-06	9.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	3.78e-06	9.56e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	3.75e-06	9.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.72e-06	9.4e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	3.67e-06	9.28e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	3.65e-06	9.24e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.64e-06	9.21e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.64e-06	9.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.63e-06	9.19e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.63e-06	9.18e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.63e-06	9.18e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.63e-06	9.18e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.62e-06	9.16e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.6e-06	9.11e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.6e-06	9.11e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	3.59e-06	9.07e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	3.57e-06	9.03e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.57e-06	9.03e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.56e-06	9.01e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.55e-06	8.98e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.55e-06	8.98e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.53e-06	8.93e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.51e-06	8.88e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	3.51e-06	8.88e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	3.5e-06	8.86e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	3.5e-06	8.85e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.49e-06	8.84e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	3.49e-06	8.82e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.48e-06	8.81e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.48e-06	8.81e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.48e-06	8.8e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.46e-06	8.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.46e-06	8.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.46e-06	8.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.46e-06	8.75e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.46e-06	8.74e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.45e-06	8.73e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.45e-06	8.73e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.44e-06	8.7e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	3.43e-06	8.68e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	3.42e-06	8.65e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	3.41e-06	8.62e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.38e-06	8.54e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.36e-06	8.51e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.36e-06	8.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.36e-06	8.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.36e-06	8.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.36e-06	8.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.34e-06	8.44e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	3.33e-06	8.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.33e-06	8.42e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.32e-06	8.4e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.32e-06	8.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	3.31e-06	8.38e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	3.29e-06	8.32e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.28e-06	8.31e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.28e-06	8.31e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.26e-06	8.24e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	3.25e-06	8.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	3.25e-06	8.21e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.23e-06	8.17e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.22e-06	8.15e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.21e-06	8.12e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.2e-06	8.1e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.19e-06	8.06e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.17e-06	8.01e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	3.16e-06	7.98e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.15e-06	7.96e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.15e-06	7.96e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.11e-06	7.87e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.1e-06	7.85e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.1e-06	7.85e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.1e-06	7.85e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.1e-06	7.83e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.07e-06	7.76e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.06e-06	7.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.05e-06	7.7e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.02e-06	7.63e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.02e-06	7.63e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.01e-06	7.6e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3e-06	7.58e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3e-06	7.58e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.98e-06	7.53e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.98e-06	7.53e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.98e-06	7.53e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.97e-06	7.51e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-06	7.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.95e-06	7.47e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2.95e-06	7.46e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	2.94e-06	7.43e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.92e-06	7.39e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	2.9e-06	7.34e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.9e-06	7.33e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.84e-06	7.18e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.84e-06	7.18e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.81e-06	7.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.8e-06	7.07e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	2.77e-06	7.02e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-06	6.98e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.74e-06	6.93e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.74e-06	6.93e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.74e-06	6.92e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.73e-06	6.9e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.72e-06	6.89e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.71e-06	6.86e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.71e-06	6.86e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.71e-06	6.85e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.7e-06	6.83e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.69e-06	6.8e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.69e-06	6.8e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.69e-06	6.8e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.68e-06	6.79e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.68e-06	6.78e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.67e-06	6.75e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.67e-06	6.75e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.67e-06	6.75e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.67e-06	6.75e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.66e-06	6.74e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.65e-06	6.71e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-06	6.71e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-06	6.69e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.62e-06	6.62e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.61e-06	6.59e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.59e-06	6.54e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.58e-06	6.52e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.57e-06	6.51e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.57e-06	6.49e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.56e-06	6.47e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.55e-06	6.45e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-06	6.43e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.52e-06	6.37e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.51e-06	6.35e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.47e-06	6.25e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-06	6.17e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.43e-06	6.15e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.43e-06	6.15e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.42e-06	6.12e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.41e-06	6.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.39e-06	6.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.39e-06	6.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.39e-06	6.06e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-06	6.05e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.35e-06	5.95e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.35e-06	5.95e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.35e-06	5.94e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.33e-06	5.89e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.32e-06	5.86e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.32e-06	5.86e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.32e-06	5.86e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.32e-06	5.86e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.31e-06	5.84e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.3e-06	5.82e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.29e-06	5.79e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.28e-06	5.77e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-06	5.76e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.28e-06	5.76e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.27e-06	5.74e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.25e-06	5.69e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.25e-06	5.69e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-06	5.68e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.22e-06	5.63e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.21e-06	5.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.2e-06	5.57e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.2e-06	5.57e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.19e-06	5.54e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.18e-06	5.52e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.17e-06	5.48e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.17e-06	5.48e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.15e-06	5.44e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.11e-06	5.35e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.11e-06	5.34e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.08e-06	5.27e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.08e-06	5.26e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.08e-06	5.25e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.08e-06	5.25e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.07e-06	5.24e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.07e-06	5.23e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.07e-06	5.22e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.06e-06	5.21e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.06e-06	5.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.05e-06	5.19e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.05e-06	5.18e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-06	5.09e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.01e-06	5.07e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.98e-06	5.01e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-06	5e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.95e-06	4.94e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.94e-06	4.91e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.93e-06	4.89e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.9e-06	4.81e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.89e-06	4.79e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.86e-06	4.72e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.81e-06	4.57e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.8e-06	4.56e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.8e-06	4.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.79e-06	4.53e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.79e-06	4.53e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.78e-06	4.51e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.78e-06	4.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.78e-06	4.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.77e-06	4.48e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.77e-06	4.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.76e-06	4.45e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.75e-06	4.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.75e-06	4.42e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.71e-06	4.32e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	4.3e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	4.3e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.66e-06	4.2e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.63e-06	4.12e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.62e-06	4.1e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.61e-06	4.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.59e-06	4.03e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.59e-06	4.02e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.58e-06	3.99e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	3.94e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.55e-06	3.92e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.55e-06	3.92e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.55e-06	3.92e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.54e-06	3.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.53e-06	3.87e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.51e-06	3.82e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.47e-06	3.71e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.44e-06	3.64e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-06	3.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.39e-06	3.53e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.39e-06	3.51e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.37e-06	3.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.37e-06	3.45e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.35e-06	3.41e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-06	3.35e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-06	3.35e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	3.07e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.21e-06	3.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.19e-06	3.01e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.17e-06	2.95e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.12e-06	2.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.07e-06	2.71e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	2.62e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.02e-06	2.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.02e-06	2.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	2.56e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.36e-07	2.37e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	7.82e-07	1.98e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.13e-07	1.8e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.09e-07	1.54e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.7e-07	1.19e-05	CbGpPWpGaD
